Vimab Group Ab Stock Operating Margin
| VIMAB Stock | 7.50 0.25 3.23% |
VIMAB Group AB fundamentals help investors to digest information that contributes to VIMAB Group's financial success or failures. It also enables traders to predict the movement of VIMAB Stock. The fundamental analysis module provides a way to measure VIMAB Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to VIMAB Group stock.
VIMAB |
VIMAB Group AB Company Operating Margin Analysis
VIMAB Group's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, VIMAB Group AB has an Operating Margin of 0.0%. This is 100.0% lower than that of the Industrials sector and about the same as Consulting Services (which currently averages 0.0) industry. The operating margin for all Sweden stocks is 100.0% lower than that of the firm.
VIMAB Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses VIMAB Group's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of VIMAB Group could also be used in its relative valuation, which is a method of valuing VIMAB Group by comparing valuation metrics of similar companies.VIMAB Group is currently under evaluation in operating margin category among its peers.
VIMAB Fundamentals
| Return On Equity | 2.92 | |||
| Return On Asset | -0.0135 | |||
| Current Valuation | 202.7 M | |||
| Shares Outstanding | 19.4 M | |||
| Shares Owned By Insiders | 7.69 % | |||
| Price To Book | 2.44 X | |||
| Price To Sales | 0.96 X | |||
| Revenue | 70.34 M | |||
| Gross Profit | 115.7 M | |||
| EBITDA | (2.11 M) | |||
| Book Value Per Share | 4.81 X | |||
| Earnings Per Share | 50.93 X | |||
| Number Of Employees | 10 | |||
| Beta | 1.74 | |||
| Market Capitalization | 195.96 M | |||
| Annual Yield | 3.71 % |
About VIMAB Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze VIMAB Group AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VIMAB Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VIMAB Group AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for VIMAB Stock Analysis
When running VIMAB Group's price analysis, check to measure VIMAB Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VIMAB Group is operating at the current time. Most of VIMAB Group's value examination focuses on studying past and present price action to predict the probability of VIMAB Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VIMAB Group's price. Additionally, you may evaluate how the addition of VIMAB Group to your portfolios can decrease your overall portfolio volatility.